NCT01038037 First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01036087 Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer Status COMPLETED Phase PHASE2
NCT01031212 ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors Status WITHDRAWN Phase PHASE1
NCT01026467 Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase N/A
NCT01024712 Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT01020864 Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer Status WITHDRAWN Phase PHASE2
NCT01020786 A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients Status COMPLETED Phase PHASE4
NCT01016054 A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer Status TERMINATED Phase PHASE1
NCT01015118 LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Status COMPLETED Phase PHASE3
NCT01014767 Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors Status TERMINATED Phase PHASE3
NCT01014351 Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT01009983 Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT01009346 RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN Status TERMINATED Phase PHASE1/PHASE2
NCT01009190 A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens Status COMPLETED Phase PHASE1
NCT01005329 Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer Status COMPLETED Phase PHASE2
NCT01004172 Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases Status COMPLETED Phase PHASE2
NCT01001910 Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Status COMPLETED Phase PHASE2
NCT01000896 Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel Status WITHDRAWN Phase PHASE1
NCT00998192 A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung Status COMPLETED Phase PHASE2